share_log

Shuttle Pharmaceuticals | 8-K: Shuttle Pharmicals Receives Notice of Nasdaq's Failure to Satisfy Continued Listing Rules and CEO Anatoly Dritschilo to Attend Emerging Growth Conference on March 6, 2024

Shuttle Pharmaceuticals | 8-K: Shuttle Pharmicals Receives Notice of Nasdaq's Failure to Satisfy Continued Listing Rules and CEO Anatoly Dritschilo to Attend Emerging Growth Conference on March 6, 2024

Shuttle Pharmaceuticals | 8-K:Shuttle Pharmicals收到纳斯达克未能满足继续上市规则通知及首席执行官Anatoly Dritschilo将出席2024年3月6日新兴增长会议
美股SEC公告 ·  03/05 09:02
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息